SP
BravenNow
Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares
| USA | economy | ✓ Verified - investing.com

Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares

Entity Intersection Graph

No entity connections available yet for this article.

}
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Oil extends weekly gains as Iran conflict rages on, with crude surging around 18% Trump replaces Homeland Security chief Kristi Noem Wall Street ends lower on escalating Iran conflict, report of AI export curbs Trump says he must be involved in selecting Iran’s next leader (South Africa Philippines Nigeria) Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares By Insider Trading Published 03/05/2026, 07:55 PM Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares 0 ADPT -3.10% Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (NASDAQ:ADPT) , sold a total of 92,823 shares of common stock between March 3 and March 5, 2026, for approximately $1.49 million. The sales occurred at prices ranging from $15.49 to $16.60 per share. The stock currently trades at $15.93, up 105% over the past year, though InvestingPro analysis suggests the shares may be overvalued relative to its Fair Value estimate. Investors can explore this and other potentially overvalued stocks for deeper market insights. The Adaptive Biotechnologies executive also acquired shares through the exercise of stock options. On March 3, 4, and 5, Rubinstein exercised options to acquire a total of 73,610 shares of Adaptive Biotechnologies common stock at prices of $6.55 and $12.14, for a total value of $721,993. For comprehensive analysis including additional ProTips and detailed metrics, ADPT is among the 1,400+ US equities covered by InvestingPro’s Pro Research Reports. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. In other recent news, Adaptive Biotechnologies Corp reported impressive fourth-quarter 2025 earnings, surpassing analyst expectations. The company posted an earnings per share of -$0.09, which was a 50% positive surprise compared to the forecasted -$0.18. Revenue also exceeded expectations, reaching $71.7 million,...
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine